ARPC1B

Chr 7AR

actin related protein 2/3 complex subunit 1B

Also known as: ARC41, IMD71, PLTEID, p40-ARC, p41-ARC

This gene encodes one of seven subunits of the human Arp2/3 protein complex. This subunit is a member of the SOP2 family of proteins and is most similar to the protein encoded by gene ARPC1A. The similarity between these two proteins suggests that they both may function as p41 subunit of the human Arp2/3 complex that has been implicated in the control of actin polymerization in cells. It is possible that the p41 subunit is involved in assembling and maintaining the structure of the Arp2/3 complex. Multiple versions of the p41 subunit may adapt the functions of the complex to different cell types or developmental stages. This protein also has a role in centrosomal homeostasis by being an activator and substrate of the Aurora A kinase. [provided by RefSeq, Mar 2011]

Primary Disease Associations & Inheritance

Immunodeficiency 71 with inflammatory disease and congenital thrombocytopeniaMIM #617718
AR
403
ClinVar variants
46
Pathogenic / LP
0.01
pLI score
0
Active trials
Clinical SummaryARPC1B
🧬
Gene-Disease Validity (ClinGen)
platelet abnormalities with eosinophilia and immune-mediated inflammatory disease · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.34) despite low pLI — interpret in context.
📋
ClinVar Variants
46 Pathogenic / Likely Pathogenic· 149 VUS of 403 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.65LOEUF
pLI 0.011
Z-score 2.75
OE 0.34 (0.190.65)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
1.18Z-score
OE missense 0.79 (0.700.89)
200 obs / 252.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.34 (0.190.65)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.79 (0.700.89)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.98
01.21.6
LoF obs/exp: 7 / 20.4Missense obs/exp: 200 / 252.8Syn Z: 0.15

ClinVar Variant Classifications

403 submitted variants in ClinVar

Classification Summary

Pathogenic38
Likely Pathogenic8
VUS149
Likely Benign194
Benign12
Conflicting2
38
Pathogenic
8
Likely Pathogenic
149
VUS
194
Likely Benign
12
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
13
2
22
1
38
Likely Pathogenic
6
1
1
0
8
VUS
3
127
18
1
149
Likely Benign
0
5
92
97
194
Benign
0
2
6
4
12
Conflicting
2
Total22137139103403

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ARPC1B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia

MIM #617718

Molecular basis of disorder known

Autosomal recessive
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Description of a Novel Pathogenic Variant in the ARPC1B and a Severe Allergy in Two Infants.
Zaveleta Martínez O et al.·Iran J Allergy Asthma Immunol
2024Case report
Allergic manifestations of actinopathies: A review.
Gard CN et al.·J Allergy Clin Immunol
2025Review
Top 10 resultsSearch PubMed ↗

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →